Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms.
Symes EO, Wang P, Sojitra P, Menon MP, Patel AA, Hasan F, Ghosh S, Roloff GW, Zhou Q, Findley A, Badar T, Zhang J, Tariq H, Chang H, Bell RC, Perry AM, Venkataraman G.
Symes EO, et al. Among authors: perry am.
Br J Haematol. 2024 Nov 17. doi: 10.1111/bjh.19895. Online ahead of print.
Br J Haematol. 2024.
PMID: 39551719